Research groups
Teaching
Teaching:
- Tumor Biology; BMED 331 (https://www.uib.no/emne/BMED331). Topics: Tumor Ecosystem, Treatments and resistance
- Methods in Biomedical Research; BMED320 (Methods in Biomedical Research | Universitetet i Bergen (uib.no)
Supervision:
- PhD-candidates: 3
- MSc students: 8
- Medicine students: 2
- BSc students: 2
Publications
Academic article
- Justin Vareecal Joseph; Capucine R. Magaut; Simon Humberto Storevik et al. (2021). TGF-β promotes microtube formation in glioblastoma through thrombospondin 1. (external link)
- Jubayer Hossain; Lars Andreas Rømo Ystaas; Jelena Mrdalj et al. (2016). Lentiviral HSV-Tk.007-mediated suicide gene therapy is not toxic for normal brain cells. (external link)
- Krishna Mukharji Talasila; Gro Vatne Røsland; Hanne Røland Hagland et al. (2017). The angiogenic switch leads to a metabolic shift in human glioblastoma. (external link)
- Wenjing Zhou; Elena Martinez-Garcia; Katharina Sarnow et al. (2025). Development of a highly differentiated rat brain organoid model for exploring glioblastoma invasion dynamics and therapy. (external link)
- Ege Solel; Egil Brudvik; Lars Andreas Rømo Ystaas et al. (2025). Gasdermin E in glioblastoma –pyroptosis resistance and tumor-promoting functions. (external link)
- Tiago Ferreira; Amit Kulkarni; Clemens Bretscher et al. (2022). Oncolytic H-1 Parvovirus Hijacks Galectin-1 to Enter Cancer Cells. (external link)
- Dongxu Zhao; Huabin Zhang; Ramazan Uyar et al. (2021). Comparing tumor cell invasion and myeloid cell composition in compatible primary and relapsing glioblastoma. (external link)
- Eskil Eskilsson; Gro Vatne Røsland; Krishna Mukharji Talasila et al. (2016). EGFRvIII mutations can emerge as late and heterogenous events in glioblastoma development and promote angiogenesis through Src activation. (external link)
- Jubayer Hossain; Md Abdul Latif; Lars Andreas Rømo Ystaas et al. (2019). Long-term treatment with valganciclovir improves lentiviral suicide gene therapy of glioblastoma. (external link)
- Dionysios C. Watson; Defne Bayik; Simon Humberto Storevik et al. (2023). GAP43-dependent mitochondria transfer from astrocytes enhances glioblastoma tumorigenicity. (external link)
- Amit Kulkarni; Tiago Ferreira; Clemens Bretscher et al. (2021). Oncolytic H-1 parvovirus binds to sialic acid on laminins for cell attachment and entry. (external link)
- Jubayer Hossain; Hrvoje Miletic (2020). Letter regarding "Extensive brainstem infiltration, not mass effect, is a common feature of end-stage cerebral glioblastomas". (external link)
Academic book chapter
Master’s thesis
- Ege Solel; Hrvoje Miletic; Jubayer Hossain (2019). Use of Gap Junction Enhanching Drugs to Increase the Bystander Effect of Sucide Gene Therapy for Glioblastoma Treatment. (external link)
- Shakiba Mahdavi; Md Jubayer al Hossain; Hrvoje Miletic et al. (2024). Investigation of cell death pathways in glioblastoma in the context of suicide gene therapy. (external link)
- Gracious Takayidza; Ege Solel; Md Jubayer al Hossain et al. (2023). Investigation of the apoptotic pathway in glioblastoma in the context of suicide gene therapy. (external link)
- Sayintha Jeyendran; Jubayer Hossain; Hrvoje Miletic (2020). Studies on the Molecular Mechanisms of the Bystander Effect in HSV-TK mediated Suicide Gene Therapy for Glioblastoma Treatment. (external link)
- Jiwan Ghimire; Jubayer Hossain; Hrvoje Miletic (2017). Screening of tumor suppressor microRNAs to boost the killing efficacy of suicide gene therapy for brain cancer treatment. (external link)
Non-fiction book chapter
Academic literature review
- Johannes Kaasa Andersen; Hrvoje Miletic; Md Jubayer al Hossain (2022). Tumor-associated macrophages in gliomas—basic insights and treatment opportunities. (external link)
- Jubayer Hossain; Antonio Marchini; Boris Fehse et al. (2020). Suicide gene therapy for the treatment of high-grade glioma: Past lessons, present trends, and future prospects. (external link)
See a complete overview of publications in Cristin.
2023
1. Deciphering human glioblastoma invasion using a fully differentiated rat brain organoid model. Zhou W, ……Hossain JA, …Bjerkvig R. (Submitted). 2023. IF: Ikke aktuelt
2. Sajib SS, Hossain JA and Das MK. Stem Cell-Based Regenerative Medicine Therapy in Cancer. In: Haider, K.H. (eds) Handbook of Stem Cell Applications. Springer, Aug, 2023 IF: Ikke aktuelt
3. Watson D, …… Hossain JA…Lathia J. GAP43-dependent mitochondria transfer from astrocytes enhances glioblastoma tumorigenicity. Nature Cancer, May, 2023, IF: 23.1
2022
4. Ferreira T, ….. Hossain JA, ……and Marchini A. Oncolytic H-1 Parvovirus Hijacks Galectin-1 to Enter Cancer Cells. Viruses . 2022 May 11;14(5):1018, IF 5.8
5. Andersen JK, Miletic H, Hossain JA*. Tumor-associated macrophages in gliomas – basic insights and treatment opportunities. Cancers (Basel) . 2022 Mar 4;14(5):1319., IF 6.6
2021
6. Joseph JJ, Magaut CR, ….. Hossain JA, …., Daubon T, Miletic H. TGF-β promotes microtube formation in glioblastoma through Thrombospondin. Neuro Oncol . 2022 Apr 1;24(4):541-55. IF: 15.9
7. Zhao D, Zhang H, ….. Hossain JA, … Glass R 1and Kälin R. Comparing Tumor Cell Invasion and Myeloid Cell Composition in Compatible Primary and Relapsing Glioblastoma. Cancers 2021, 13. 2021. IF: 6.6
8. Kulkarni A, Ferreira T, ……., Hossain JA, ……Brino L and Marchini A. Oncolytic H1-parvovirus hijacks laminins for cell attachment and entry. Nat Commun. 2021 Jun 22;12(1). IF: 14.9
9. The Potentials and Pitfalls of Using Adult Stem Cells in Cancer Treatment. Das MK, Miletic H, and Hossain JA*. Advances in Experimental Medicine and Biology. 2021. IF: 2.4.
2020
10. Hossain JA, Miletic H. Letter regarding “Extensive brainstem infiltration, not mass effect, is a common feature of end-stage cerebral glioblastomas”. Neuro-Oncology. 2020. IF: 15.9
11. Hossain JA*, Marchini A, Fehse B, Bjerkvig R and Miletic H. Suicide Gene Therapy for the treatment of High-grade Gliomas: Past Lessons, Present Trend and Future Remarks. NeuroOncology Advances, 2 (1) 2020.. IF: N/A 2019
12. Hossain JA, Ystaas LAR, Latif MA, Ninzima S, Joseph JV, Talasila KM, Ghimire J, Riecken K, Fehse B, Bjerkvig R and Miletic H. Long-term treatment with valganciclovir improves lentiviral suicide gene therapy of glioblastoma, Neuro-Oncology, 21(7). 2019. IF: 15.9
13. Hossain JA, Riecken K, Miletic H, Fehse B. Cancer Suicide Gene Therapy with TK.007. Methods Mol Biol. 2019; 1895:11-26. IF: 1.29. før 2019
14. Talasila KM, Røsland GV, Hagland HR, …. Joseph JV, Hossain JA, Vallar L, ……. Bjerkvig R and Miletic H. The angiogenic switch leads to a metabolic shift in human glioblastoma. Neuro Oncol. 2017 Mar 1;19(3):383-393. IF: 15.9
15. Eskilsson E, Rosland GV, ……Välk K, Al Hossain J, ....Bjerkvig R, and Miletic H. EGFRvIII mutations can emerge as late and heterogenous events in glioblastoma development and promote angiogenesis through Src activation. Neuro Oncol. 2016 Dec;18(12):1644-1655. Epub 2016 Jun 10. IF: 15.9
16. Hossain JA, Ystaas LR, Mrdalj J, Välk K, Riecken K, Fehse B, Bjerkvig R, Grønli J,Miletic H. Lentiviral HSV-Tk.007 mediated suicide gene therapy is not toxic for normal brain cells. J Gene Med. 18(9).2016. IF: 4.5 17. Samoylenko A*, Hossain JA*, Mennerich D, Kellokumpu S, Hiltunen JK, Kietzmann T. Nutritional Countermeasures Targeting Reactive Oxygen Species in Cancer: From Mechanisms to Biomarkers and Clinical Evidence. Antioxid Redox Signal. 2013 Dec 10; 19(17): 2157–2196. *Co-first author. IF: 8.4
Projects
- Anti-cancer Therapy
- Immunotherapy of solid cancers
- Suicide Gene Therapy for the Treatment of Brain tumors
- Oncolytic Virotherapy by H1 PV Virus for the Treatment of Various Cancers
- Molecular Mechanism of Bystander effect in HSV-TK/GCV Gene therapy